Aspiration Control Systems Market Size, Share, and COVID-19 Impact Analysis By Product Type (Basic Aspiration System, Mechanical Aspiration with Integrated Control), By Application (Joint Fluid Aspiration, Ascitic Fluid Aspiration, Cerebro Spinal Fluid Aspiration, Bone Marrow Aspiration, and Others), and By End User (Hospitals & ASCs, Specialty Clinics, and Diagnostic Centers), and Regional Forecast, 2024-2032

In medical terms, aspiration refers to the withdrawal of fluid from the body. This procedure is considered essential for sample collection prior to any diagnostic or therapeutic application and to determine the course of treatment in the future.

The aspiration control system includes a fully automated sterile system with a motor and a vacuum pump which is used to control precise and continuous variable vacuum chambers. The device also includes a surgical handheld piece for a convenient aspiration of body fluid and bone marrow during a surgical procedure. The system works on suction technology which is used to adjust the mechanical vacuum controller thus maintaining favorable vacuity with sensitive suction power.

Rising awareness among people regarding the early detection of various conditions is leading to the increasing demand for aspiration control products in these diagnostic procedures. Therefore, to cater to the increasing demand, major players focus on developing technologically advanced devices, thus, driving the market's growth.

Impact of COVID-19 on Aspiration Control Systems Market 

The COVID-19 pandemic created significant disruptions in the functioning of healthcare institutions worldwide. Several factors such as the closure of diagnostic centers, travel restrictions, and lockdowns in many countries led to the delay in diagnostic procedures, therefore limiting the adoption of aspiration control systems during the pandemic.

However, emergency surgeries such as endovascular thrombectomy (EVT) were performed, as there should not be any delay while performing that procedure even during a pandemic. Additionally, people who were scheduled for a bone marrow transplant were highly susceptible to SARS CoV-2 virus. Therefore, strict measures were taken while performing those procedures.

In 2021, as the number of COVID-19 cases reduced, all the surgeries scheduled before the pandemic were performed and the market slowly gained traction. Thus increasing the adoption of aspiration control systems in hospitals and diagnostic centers.

Key Insights:

• Prevalence of Pneumonia – By Key Country/Region, 2021/ 2022.


• Key Industry developments- Partnerships, Mergers, and New Product Launches, Etc.


• Overview: Technological advancements in the aspiration control systems market.


• Impact of COVID-19 on the Market.

Analysis by Application:

Based on product type, the market is bifurcated into basic aspiration system and mechanical aspiration system with integrated control. The mechanical aspiration system with integrated control is expected to hold a dominant share of the aspiration control system market. The segment is driven by the growing adoption of such devices during surgical procedures. Furthermore, the growing adoption of these devices in diagnostic centres across the globe also propels the segment’s growth.

In addition to this major market players are cautiously working on introducing new products in this segment which leads to its domination in the aspiration control systems market.

• For instance, in April 2022, Penumbra Inc. announced its Indigo Aspiration System with Lightening 7 and Lightening 12 received CE market approval and is commercially available in Europe.

Regional Analysis:

North America market holds the largest share in the market due to the presence of major players in the region. Furthermore, the rising per capita healthcare expenditure and increased research and development initiatives in the region along with an increasing number of surgical procedures such as bone marrow transplant drives the adoption of the aspiration control system in North America.

Furthermore, the rising prevalence of acute ischemia illness in the U.S. also contributes to the adoption of these devices.

• For instance, according to an article published in NCBI in 2021, the incidence of AIS was 243 per 100,000 Americans among males and 229 per 100,000 Americans among females.

Europe is expected to show lucrative growth in the forecast period. This is due to the awareness regarding early diagnosis of diseases in the region. Furthermore, increasing R&D expenditure and the high adoption rate of technologically advanced devices in the region spur the growth of the market.

Key Players: 

The report will include the profiles of key players such as Abbott, Penumbra, Inc., VACUUBRAND GMBH + CO KG, INTEGRA Biosciences AG, Gilson Incorporated, Hettich Benelux B.V.,

Segmentation:

Key Industry Developments:

• September 2022: Scopio Labs announced the launch of a Full-Field Bone Marrow Aspitate application. This platform is the first to enable a complete digital workflow for bone marrow aspirate scanning and analysis.


• September 2021: Abbott announced the acquisition of Walk Vascular, LLC, and expanded their existing endovascular product portfolio with their peripheral thrombectomy system.